Clinical Effectiveness of Ritonavir-Boosted Nirmatrelvir—A Literature Review
Nirmatrelvir/Ritonavir is an oral treatment for mild to moderate COVID-19 cases with a high risk for a severe course of the disease. For this paper, a comprehensive literature review was performed, leading to a summary of currently available data on Nirmatrelvir/Ritonavir’s ability to reduce the ris...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-01-01
|
| Series: | Advances in Respiratory Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2543-6031/92/1/9 |